Patents by Inventor Sushrut Krishnaji Kulkarni

Sushrut Krishnaji Kulkarni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140343076
    Abstract: The present invention relates to pharmaceutical compositions of lurasidone or salts thereof. In particular, the invention relates to pharmaceutical compositions of lurasidone or salts thereof with one or more acids. The invention also relates to processes for the preparation of such compositions and use thereof for treatment of schizophrenia, bipolar disorders or senile dementia.
    Type: Application
    Filed: May 15, 2014
    Publication date: November 20, 2014
    Applicant: Cadila Healthcare Limited
    Inventors: Sushrut Krishnaji Kulkarni, Ajay Kumar Handa, Doss Pothuvan Uma, Yagnesh Atulkumar Bhatt
  • Publication number: 20140243383
    Abstract: The present invention discloses a stable pharmaceutical composition comprising: (a) plurality of granules comprising silodosin or salts thereof and one or more pharmaceutical excipients; and (b) an extragranular portion comprising one or more lubricants and optionally one or more surfactants, wherein the granules are free of partially pregelatinized starch.
    Type: Application
    Filed: August 24, 2012
    Publication date: August 28, 2014
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Ajay Kumar Handa, Doss Pothuvan Uma
  • Publication number: 20140199401
    Abstract: A stable extend release pharmaceutical composition is disclosed.
    Type: Application
    Filed: July 4, 2012
    Publication date: July 17, 2014
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Ajay Kumar Handa, Ketan Tulsidas Savjani
  • Publication number: 20140199382
    Abstract: The present invention relates to a stable pharmaceutical composition comprising an S1P receptor agonist and one or more pharmaceutically acceptable excipients, wherein the composition is free of a sugar alcohol. It also relates to method of preparing such compositions and using those compositions in the treatment of multiple sclerosis.
    Type: Application
    Filed: January 10, 2014
    Publication date: July 17, 2014
    Applicant: Cadila Healthcare Limited
    Inventors: SUSHRUT KRISHNAJI KULKARNI, AJAYKUMAR HANDA, PRUDHVI RAJU DANTULURI
  • Publication number: 20140004189
    Abstract: Modified release pharmaceutical compositions of memantine or pharmaceutically acceptable salts thereof are described. The compositions of invention are stable, possess improved formulation characteristics and also provide extended therapeutically effective plasma levels over a twenty four hours period. Processes of making these compositions are also described.
    Type: Application
    Filed: January 25, 2012
    Publication date: January 2, 2014
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Sandhya Rajendra Shenoy, Imran Shakoor Ghogari, Vijaykumar Shivajrao Patil
  • Publication number: 20130267560
    Abstract: The present invention relates to sustained release pharmaceutical compositions of donepezil or pharmaceutically acceptable salts thereof. The compositions of the invention are stable and provide sustained therapeutically effective plasma levels over a twenty four hour period with reduced incidences of cholinergic side effects. The invention also relates to process of making such compositions.
    Type: Application
    Filed: October 24, 2011
    Publication date: October 10, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Roy, Sushrut Krishnaji Kulkarni, Ajaykumar Handa
  • Publication number: 20130243861
    Abstract: The present invention provides for press-coated tablets of prednisone comprising a core comprising prednisone and a coating around the core. The present invention particularly discloses thickness of the coating applied to core having a convex shape for chronotherapeutic use. The present invention also provides for a process for preparing a press-coated tablet of prednisone and a method for treating conditions or pathology, the symptoms of which occur early in the morning.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 19, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan ROY, Sushrut Krishnaji KULKARNI, Ajaykumar HANDA, Ketan Tulsidas SAVJANI
  • Publication number: 20130216617
    Abstract: The present invention relates to stable pharmaceutical compositions of (R)-lansoprazole or pharmaceutically acceptable salts thereof and process of preparing the same. The invention particularly provides pharmaceutical compositions of optically active (R)-isomer of lansoprazole with at least two functional coating layers.
    Type: Application
    Filed: June 28, 2011
    Publication date: August 22, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Manohar Vishwanath Lalge, Vaibhav Panditrao Deshmukh
  • Publication number: 20130209553
    Abstract: The present invention discloses an extended release pharmaceutical composition of pramipexole or salts thereof comprising at least 40% w/w of hydrogenated castor oil, and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: April 15, 2011
    Publication date: August 15, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Ajay Kumar Handa, Pranav Dhirajbhai Jogani
  • Publication number: 20130202688
    Abstract: The present invention relates to delayed release oral disintegrating pharmaceutical compositions of lansoprazole or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of such compositions.
    Type: Application
    Filed: May 3, 2011
    Publication date: August 8, 2013
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Hemant Manilal Mamania
  • Publication number: 20130172411
    Abstract: The present invention relates to stable pharmaceutical compositions comprising fesoterodine or salts thereof. In particular, the invention relates to pharmaceutical compositions of fesoterodine which does not contain sugar alcohols. The invention also relates to processes for making such compositions and use thereof in treating patients with urinary incontinence.
    Type: Application
    Filed: March 22, 2011
    Publication date: July 4, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Pranav Jogani Dhirajbhai, Ajay Handa Kumar
  • Publication number: 20130095144
    Abstract: The present invention discloses a stable solid pharmaceutical matrix composition comprising sirolimus or pharmaceutically acceptable salts thereof along with one or more sugars.
    Type: Application
    Filed: April 25, 2011
    Publication date: April 18, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Kiritkumar Maulik Panchal, Shubhashchandra Shailendra Mandge
  • Publication number: 20120207825
    Abstract: A pharmaceutical composition is disclosed. The composition comprises a core comprising an active substance or a salt thereof; a separating layer comprising at least one sugar; and a functional layer comprising at least one pharmaceutically acceptable polymer, wherein the composition is resistant to dose dumping in presence of alcohol.
    Type: Application
    Filed: September 9, 2010
    Publication date: August 16, 2012
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Maulik Kiritkumar Panchal, Kartik Yogeshkumar Shah
  • Publication number: 20100239661
    Abstract: A pharmaceutical composition is disclosed. The composition comprises a therapeutically effective amount of active pharmaceutical ingredient that is Ursodiol or its pharmaceutically acceptable salts thereof with one or more pharmaceutically acceptable excipients, wherein said active pharmaceutical ingredient present in the form of micronized and unmicronized particles in the ratio about 5:95 to about 95:5.
    Type: Application
    Filed: October 23, 2007
    Publication date: September 23, 2010
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Babulal Patel Dharmesh